John V. Balen - May 14, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk L. Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
May 14, 2021
Transactions value $
$287,600
Form type
4
Date filed
6/1/2021, 05:03 PM
Next filing
Jun 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Purchase $91.6K +1K +4.15% $91.57 25.1K May 14, 2021 Direct F1
transaction CDLX Common Stock Purchase $92.9K +1K +3.99% $92.92 26.1K May 14, 2021 Direct F2
transaction CDLX Common Stock Purchase $103K +1K +3.84% $103.11 27.1K May 25, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Award $0 +1.7K $0.00 1.7K May 21, 2021 Common Stock 1.7K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $91.565 to $91.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
F2 The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $92.8863 to $92.98, inclusive.
F3 The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $102.68 to $103.43, inclusive.
F4 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5 The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.